As of 2025-09-13, the Relative Valuation of Arena Pharmaceuticals Inc (ARNA) is (146.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 99.99 USD, the upside of Arena Pharmaceuticals Inc based on Relative Valuation is -247.0%.
The range of the Relative Valuation is (138.56) - (155.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 15.5x | 14.7x |
| Forward P/E multiples | 13.8x - 15.6x | 14.7x |
| Fair Price | (138.56) - (155.35) | (146.96) |
| Upside | -238.6% - -255.4% | -247.0% |
| Date | P/E |